Mizuho’s Jared Holz on what is next for Sarepta after second death connected to gene therapy

Mizuho’s Jared Holz on what is next for Sarepta after second death connected to gene therapy

June 16, 2025

Jared Holz, Mizuho, joins ‘Fast Money’ to talk the fallout for Sarepta after another death related to its muscular dystrophy gene therapy.

Share This

Latest Mizuho News

Mizuho Americas and NPower advance tech career pathways for New Yorkers through Path2TECH: NetSA

Mizuho Americas and NPower advance tech career pathways for New Yorkers through Path2TECH: NetSA

January 8, 2026

Mizuho Americas announces $1 million in grants through the Mizuho USA Foundation

Mizuho Americas announces $1 million in grants through the Mizuho USA Foundation

January 5, 2026

Nvidia is the most compelling tech stock you can buy right now, says Mizuho’s Jordan Klein

Nvidia is the most compelling tech stock you can buy right now, says Mizuho’s Jordan Klein

November 18, 2025

Mizuho news from around the globe

Mizuho Global News